Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Disease-specific safety and efficacy of doacs vs. LMWH for venous thromboembolism in patients with brain metastases: A real-world trinetx analysis

Ali Mushtaq, Omer Ashruf, Mohanad Baroudi, Ahmad Safdar, Alok Khorana, Dana Angelini

Blood (2025) 146 (Supplement 1): 1360.

https://doi.org/10.1182/blood-2025-1360

Published: 2025

Journal Articles

Low-dose post-transplant cyclophosphamide for GvHD prophylaxis in haploidentical stem cell transplantation: A systematic review of efficacy, toxicity, and survival outcomes

Areez Shafqat, Omar Ahmad, Mohammed Omer, Shameel Shafqat, Abdulrahman Nasiri, Ahmed Kotb, Ali Mushtaq, Mary Harnegie, Ali Al-Ahmari, Syed Ahmed, Walid Rasheed, Hazza Alzahrani, Mahmoud Aljurf, Riad Elfakih, Mostafa Saleh

Blood (2025) 146 (Supplement 1): 7775.

https://doi.org/10.1182/blood-2025-7775

Published: 2025

Journal Articles

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Blood (2025) 146 (Supplement 1): 4636.

https://doi.org/10.1182/blood-2025-4636

Published: 2025

Journal Articles

Distinct predictors of mortality and conduction disease in AL cardiac amyloidosis

Ali Mushtaq, Ahmad Safdar, Ahmed Mohamed, Wael Jaber, Walid Saliba, Faiz Anwer, Mazen Hanna

Blood (2025) 146 (Supplement 1): 3958.

https://doi.org/10.1182/blood-2025-3958

Published: 2025

Journal Articles

Trends in cardiovascular mortality in Hodgkin and non-Hodgkin lymphoma: A nationwide analysis from 1999 to 2020

Ali Mushtaq, Abhigan Shrestha, Prince Thakur, Sajjad Khan, Asfand Yar Cheema, Anuj Subedi, Gauranga Mahalwar

Blood (2025) 146 (Supplement 1): 7118.

https://doi.org/10.1182/blood-2025-7118

Published: 2025

Journal Articles

Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study

Ali Mushtaq, Omer Ashruf, Larry Cripe, Abhay Singh, John Molina, Hetty Carraway, Sudipto Mukherjee, Aaron Gerds, Akriti Jain

Blood (2025) 146 (Supplement 1): 3826.

https://doi.org/10.1182/blood-2025-3826

Published: 2025

Journal Articles

Longitudinal analysis of first and subsequent-line tyrosine kinase inhibitor use in chronic myeloid leukemia: A 16-year single-center experience

Moaath Mustafa Ali, Emily Zabor, Kamilla Abdurakhmanov, Hadil Zureigat, Ahmed Nabil, Muaz Alsabbagh Alchirazi, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Akriti Jain, John Molina, Sophia Balderman, Abhay Singh, Aaron Gerds, Anjali Advani, Hetty Carraway, Matt Kalaycio, Sudipto Mukherjee

Blood (2025) 146 (Supplement 1): 2012.

https://doi.org/10.1182/blood-2025-2012

Published: 2025

Journal Articles

Outcomes in AML Patients Admitted to the ICU Following Allogeneic Stem Cell Transplantation

Ali Mushtaq, Aastha Dhakal, John Hanna, Michael Sheu, Faiz Anwer, Zachary Yetmar, Thomas Andrew Crilley, Muhammad Anns Asif, Aneela Majeed

Blood (2024) 144 (Supplement 1): 7430.

https://doi.org/10.1182/blood-2024-202081

Published: 2024

Journal Articles

Outcomes of Accelerated and Blast Phase Chronic Myeloid Leukemia at a Tertiary Center

Ahmed N Mohamed, Hadil Zureigat, Muaz Alsabbagh Alchirazi, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Sneha Govande, Emily C. Zabor, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Matt Kalaycio, Sudipto Mukherjee, Moaath K. Mustafa Ali

Blood (2024) 144 (Supplement 1): 6610.

https://doi.org/10.1182/blood-2024-210152

Published: 2024

Journal Articles

Outcomes of Second-Line Tyrosine Kinase Inhibitors after First-Line Imatinib in Chronic Myelogenous Leukemia: A Retrospective Cohort Study

Muaz Alsabbagh Alchirazi, Hadil Zureigat, Ahmed N Mohamed, Aastha Dhakal, Ali Mushtaq, Naveen Rehman, Bryan Berube, Sneha Govande, Emily C. Zabor, Akriti G. Jain, John C. Molina, Sophia Balderman, Abhay Singh, Aaron T. Gerds, Anjali S. Advani, Hetty E. Carraway, Matt Kalaycio, Sudipto Mukherjee, Moaath K. Mustafa Ali

Blood (2024) 144 (Supplement 1): 6597.

https://doi.org/10.1182/blood-2024-206448

Published: 2024

Journal Articles

Cardiovascular Profile of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia: A 16-Year Observational Study

Blood (2024) 144 (Supplement 1): 1777.

https://doi.org/10.1182/blood-2024-212146

Published: 2024

Journal Articles

Infectious Risk in Multiple Myeloma Patients Undergoing Treatment with Teclistamab

Michael Sheu, Ali Mushtaq, Sofia Molina Garcia, Faiz Anwer, Meera Patel, Thomas Andrew Crilley, Muhammad Anns Asif, Aneela Majeed

Blood (2024) 144 (Supplement 1): 1959.

https://doi.org/10.1182/blood-2024-194386

Published: 2024

Journal Articles

Clinical Outcomes and Disease Progression after Daratumumab-Based Treatment in Primary Amyloidosis

Omer Ashruf, Ali Mushtaq, Faiza Zakaria, Razwana Khanam, Faiz Anwer

Blood (2024) 144 (Supplement 1): 1924.

https://doi.org/10.1182/blood-2024-211663

Published: 2024

Journal Articles

Cardiac Safety Profiles of First-Generation Vs. Second-Generation BTK Inhibitors: A Meta-Analysis

Ali Mushtaq, Eman Nayaz Ahmed, Roaa Aljumaa, Abdel Rahman E'mar, Osamah Badwan

Blood (2024) 144 (Supplement 1): 3017.

https://doi.org/10.1182/blood-2024-202096

Published: 2024

Journal Articles

The Concordance between Laboratory and POCT INR and the Value of Bedside Measurement of INR in Patients on Warfarin Undergoing Dental Procedures: A Prospective Cohort Study

Abdullah Albarkheel, Sr., Tarek M Owaidah, Hani Tamim, Abdullah Alahmadi, Aamir Sheikh, Ali Mushtaq

Blood (2023) 142 (Supplement 1): 5538.

https://doi.org/10.1182/blood-2023-173577

Published: 2023

Journal Articles

The Impact of Laboratory Sample Request Evaluation and the Use of Probability Testing for HIT By Trained Physician on the Decrease of Unnecessary Tests and Increase the Likelihood of Positivity

Tarek M Owaidah, Hani Tamim, Ali Mushtaq, Mohamad Aljumaa, Roaa Aljumaa

Blood (2023) 142 (Supplement 1): 5552.

https://doi.org/10.1182/blood-2023-178747

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Disease-specific safety and efficacy of doacs vs. LMWH for venous thromboembolism in patients with brain metastases: A real-world trinetx analysis

Low-dose post-transplant cyclophosphamide for GvHD prophylaxis in haploidentical stem cell transplantation: A systematic review of efficacy, toxicity, and survival outcomes

Association of socioeconomic indicators with survival in chronic myeloid leukemia: A retrospective analysis

Distinct predictors of mortality and conduction disease in AL cardiac amyloidosis

Trends in cardiovascular mortality in Hodgkin and non-Hodgkin lymphoma: A nationwide analysis from 1999 to 2020

Comparative risk of major adverse cardiovascular events in polycythemia vera patients treated with ruxolitinib, hydroxyurea, or interferon: A real-world, propensity-matched cohort study

Longitudinal analysis of first and subsequent-line tyrosine kinase inhibitor use in chronic myeloid leukemia: A 16-year single-center experience

Outcomes in AML Patients Admitted to the ICU Following Allogeneic Stem Cell Transplantation

Outcomes of Accelerated and Blast Phase Chronic Myeloid Leukemia at a Tertiary Center

Outcomes of Second-Line Tyrosine Kinase Inhibitors after First-Line Imatinib in Chronic Myelogenous Leukemia: A Retrospective Cohort Study

Cardiovascular Profile of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia: A 16-Year Observational Study

Infectious Risk in Multiple Myeloma Patients Undergoing Treatment with Teclistamab

Clinical Outcomes and Disease Progression after Daratumumab-Based Treatment in Primary Amyloidosis

Cardiac Safety Profiles of First-Generation Vs. Second-Generation BTK Inhibitors: A Meta-Analysis

The Concordance between Laboratory and POCT INR and the Value of Bedside Measurement of INR in Patients on Warfarin Undergoing Dental Procedures: A Prospective Cohort Study

The Impact of Laboratory Sample Request Evaluation and the Use of Probability Testing for HIT By Trained Physician on the Decrease of Unnecessary Tests and Increase the Likelihood of Positivity

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only